Iconovo Total Liabilities
Iconovo total liabilities. Based on the latest financial reports, Iconovo (ICO) has total liabilities worth Skr13.15 Million SEK (≈ $1.42 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Iconovo liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Iconovo (2015–2025)
Total liabilities of Iconovo from 2015 to 2025. This chart illustrates how Iconovo's total liabilities have evolved over time, based on quarterly financial data.
Iconovo Competitors by Total Liabilities
The table below lists competitors of Iconovo ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Turiya Bhd
KLSE:4359
|
Malaysia | RM35.15 Million |
|
Vogiatzoglou Systems S.A
AT:VOSYS
|
Greece | €12.35 Million |
|
Taihan Textile
KO:001070
|
Korea | ₩66.83 Billion |
|
Bravada Gold Corporation
V:BVA
|
Canada | CA$1.39 Million |
|
Algorae Pharmaceuticals Ltd
AU:1AI
|
Australia | AU$111.25K |
|
Emova Group SA
PA:ALEMV
|
France | €42.01 Million |
|
Ozerden Plastik Sanayi
IS:OZRDN
|
Turkey | TL52.79 Million |
|
Pelikan International Corp
KLSE:5231
|
Malaysia | RM64.67 Million |
Liability Composition Analysis (2015–2025)
This chart breaks down Iconovo's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see ICO total assets.
Liquidity & Leverage Metrics
Iconovo Total Liabilities Ratios Explained
Iconovo total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.06 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.09 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.08 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Iconovo's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Iconovo (2015–2025)
The table below shows the annual total liabilities of Iconovo from 2015 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | Skr13.16 Million ≈ $1.42 Million |
-20.10% |
| 2024-12-31 | Skr16.47 Million ≈ $1.77 Million |
+13.19% |
| 2023-12-31 | Skr14.55 Million ≈ $1.57 Million |
-54.48% |
| 2022-12-31 | Skr31.97 Million ≈ $3.44 Million |
+177.80% |
| 2021-12-31 | Skr11.51 Million ≈ $1.24 Million |
+38.41% |
| 2020-12-31 | Skr8.32 Million ≈ $894.85K |
+67.69% |
| 2019-12-31 | Skr4.96 Million ≈ $533.64K |
-43.11% |
| 2018-12-31 | Skr8.72 Million ≈ $937.94K |
-17.57% |
| 2017-12-31 | Skr10.57 Million ≈ $1.14 Million |
-7.06% |
| 2016-12-31 | Skr11.38 Million ≈ $1.22 Million |
+118.88% |
| 2015-12-31 | Skr5.20 Million ≈ $559.38K |
-- |
About Iconovo
Iconovo AB (publ) develops inhaled medicinal products in Sweden. The company offers ICOres, a multi-dose dry powder inhaler; ICOcap, a capsule based dry powder inhaler; ICOone, a single-dose disposable dry powder inhaler; and ICOpre, a pre-metered dry powder inhaler; and ICOone nasal single-dose dry powder inhaler for nasal use. It serves generic companies. The company has a collaboration agreeme… Read more